Variant report

Variant	rs2007756
Chromosome Location	chr3:119922347-119922348
allele	A/G
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Distal block	Cell Line	Cell type	Cell Stage
1	chr3:119917539..119919805-chr3:119921736..119924200,3	MCF-7	breast:

Extended variants
information (count: 72 )
Associated
traits (count: 0)

rSNPs within LD-proxies of this variant (count:66)

rs_ID	r²[population]
rs10049256	0.88[EUR][1000 genomes]
rs10934512	0.88[EUR][1000 genomes]
rs10934514	0.83[EUR][1000 genomes]
rs10934515	0.88[EUR][1000 genomes]
rs10934516	0.88[EUR][1000 genomes]
rs10934517	0.88[EUR][1000 genomes]
rs11707711	0.88[EUR][1000 genomes]
rs12152218	0.90[EUR][1000 genomes]
rs1352458	0.88[EUR][1000 genomes]
rs1488761	0.88[EUR][1000 genomes]
rs1488762	0.88[EUR][1000 genomes]
rs1488764	0.88[EUR][1000 genomes]
rs1907681	0.88[EUR][1000 genomes]
rs2035671	0.88[EUR][1000 genomes]
rs2130000	0.88[EUR][1000 genomes]
rs2131174	0.81[EUR][1000 genomes]
rs2171598	0.88[EUR][1000 genomes]
rs2319541	0.88[EUR][1000 genomes]
rs2319542	0.88[EUR][1000 genomes]
rs2319543	0.88[EUR][1000 genomes]
rs2874022	0.88[EUR][1000 genomes]
rs2874023	0.88[EUR][1000 genomes]
rs4488869	0.83[EUR][1000 genomes]
rs4676804	0.88[EUR][1000 genomes]
rs4676809	0.88[EUR][1000 genomes]
rs4676822	0.88[EUR][1000 genomes]
rs4676832	0.82[EUR][1000 genomes]
rs6438559	0.83[EUR][1000 genomes]
rs6438561	0.85[EUR][1000 genomes]
rs6438562	0.83[EUR][1000 genomes]
rs6438564	0.88[EUR][1000 genomes]
rs6438566	0.88[EUR][1000 genomes]
rs6438567	0.88[EUR][1000 genomes]
rs6764549	0.88[EUR][1000 genomes]
rs6769988	0.82[EUR][1000 genomes]
rs6775625	0.88[EUR][1000 genomes]
rs6776122	0.88[EUR][1000 genomes]
rs6777971	0.82[EUR][1000 genomes]
rs6782570	0.83[EUR][1000 genomes]
rs6794478	0.83[EUR][1000 genomes]
rs6805050	0.88[EUR][1000 genomes]
rs7637828	0.88[EUR][1000 genomes]
rs7641838	0.88[EUR][1000 genomes]
rs7642171	0.90[EUR][1000 genomes]
rs7653263	0.88[EUR][1000 genomes]
rs7653396	0.88[EUR][1000 genomes]
rs902790	0.88[EUR][1000 genomes]
rs902791	0.88[EUR][1000 genomes]
rs902792	0.88[EUR][1000 genomes]
rs902794	0.88[EUR][1000 genomes]
rs902795	0.82[EUR][1000 genomes]
rs923726	0.88[EUR][1000 genomes]
rs923727	0.88[EUR][1000 genomes]
rs923728	0.88[EUR][1000 genomes]
rs9289142	0.88[EUR][1000 genomes]
rs9289143	0.88[EUR][1000 genomes]
rs979682	0.88[EUR][1000 genomes]
rs9813834	0.88[EUR][1000 genomes]
rs9841122	0.88[EUR][1000 genomes]
rs9842302	0.88[EUR][1000 genomes]
rs9849023	0.83[EUR][1000 genomes]
rs9853082	0.88[EUR][1000 genomes]
rs9857123	0.88[EUR][1000 genomes]
rs9858566	0.88[EUR][1000 genomes]
rs9868058	0.85[EUR][1000 genomes]
rs9868312	0.88[EUR][1000 genomes]

Variant overlapped rSNPs/rCNVs (count:6 , 50 per page) page: 1

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	nsv949589	chr3:119560606-120175917	Flanking Active TSS Weak transcription Enhancers Active TSS ZNF genes & repeats Strong transcription Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS Genic enhancers Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	80 gene(s)	inside rSNPs	diseases
2	nsv1001476	chr3:119575386-120075417	Weak transcription Strong transcription Flanking Active TSS Enhancers Active TSS ZNF genes & repeats Bivalent/Poised TSS Genic enhancers Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Bivalent Enhancer	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	74 gene(s)	inside rSNPs	diseases
3	nsv536704	chr3:119575386-120075417	Enhancers Weak transcription ZNF genes & repeats Transcr. at gene 5' and 3' Strong transcription Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Genic enhancers Bivalent Enhancer Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	74 gene(s)	inside rSNPs	diseases
4	nsv877376	chr3:119824037-120119446	Weak transcription Strong transcription Enhancers Flanking Active TSS Active TSS Bivalent Enhancer Genic enhancers Transcr. at gene 5' and 3' Bivalent/Poised TSS ZNF genes & repeats Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	29 gene(s)	inside rSNPs	diseases
5	nsv1007557	chr3:119892894-120764353	Enhancers Strong transcription Flanking Active TSS Weak transcription ZNF genes & repeats Bivalent/Poised TSS Active TSS Genic enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	49 gene(s)	inside rSNPs	diseases
6	nsv536706	chr3:119892894-120764353	Flanking Bivalent TSS/Enh Enhancers Active TSS Weak transcription Strong transcription Genic enhancers Flanking Active TSS Transcr. at gene 5' and 3' Bivalent/Poised TSS Bivalent Enhancer ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	49 gene(s)	inside rSNPs	diseases

No data

Chromatin state (count:33 , 50 per page) page: 1

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr3:119918600-119923200	Weak transcription	Lung	lung
2	chr3:119919600-119923400	Enhancers	Fetal Adrenal Gland	Adrenal Gland
3	chr3:119920000-119922400	Enhancers	Skeletal Muscle Male	skeletal muscle
4	chr3:119920400-119923200	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
5	chr3:119921200-119922600	Flanking Active TSS	Primary neutrophils fromperipheralblood	blood
6	chr3:119921200-119922800	Enhancers	Skeletal Muscle Female	skeletal muscle
7	chr3:119921400-119922400	Enhancers	Primary hematopoietic stem cells	blood
8	chr3:119921400-119922400	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
9	chr3:119921400-119922400	Enhancers	Foreskin Fibroblast Primary Cells skin01	Skin
10	chr3:119921400-119922400	Enhancers	Foreskin Fibroblast Primary Cells skin02	Skin
11	chr3:119921400-119922400	Enhancers	Brain Cingulate Gyrus	brain
12	chr3:119921400-119922400	Enhancers	Fetal Lung	lung
13	chr3:119921400-119922400	Enhancers	Ovary	ovary
14	chr3:119921400-119922400	Enhancers	Right Atrium	heart
15	chr3:119921400-119922400	Enhancers	Hela-S3	cervix
16	chr3:119921400-119922400	Enhancers	HUVEC	blood vessel
17	chr3:119921400-119922800	Enhancers	Psoas Muscle	Psoas
18	chr3:119921400-119923000	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
19	chr3:119921400-119923000	Enhancers	Primary B cells from cord blood	blood
20	chr3:119921400-119923000	Enhancers	Primary hematopoietic stem cells short term culture	blood
21	chr3:119921400-119923200	Enhancers	Adipose Nuclei	Adipose
22	chr3:119921400-119923800	Enhancers	Liver	Liver
23	chr3:119921400-119923800	Flanking Active TSS	Monocytes-CD14+_RO01746	blood
24	chr3:119921600-119922400	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
25	chr3:119921600-119922400	Enhancers	NHDF-Ad	bronchial
26	chr3:119921800-119922400	Enhancers	HMEC	breast
27	chr3:119922000-119922400	Enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
28	chr3:119922000-119922400	Flanking Active TSS	Primary monocytes fromperipheralblood	blood
29	chr3:119922000-119922400	Enhancers	Foreskin Melanocyte Primary Cells skin03	Skin
30	chr3:119922000-119922400	Enhancers	Brain Dorsolateral Prefrontal Cortex	brain
31	chr3:119922000-119922800	Enhancers	Placenta	Placenta
32	chr3:119922200-119922400	Enhancers	Fetal Muscle Leg	muscle
33	chr3:119922200-119923000	Enhancers	Stomach Smooth Muscle	stomach

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links